BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9433129)

  • 1. The cyclin box fold: protein recognition in cell-cycle and transcription control.
    Noble ME; Endicott JA; Brown NR; Johnson LN
    Trends Biochem Sci; 1997 Dec; 22(12):482-7. PubMed ID: 9433129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural similarity between the pocket region of retinoblastoma tumour suppressor and the cyclin-box.
    Kim HY; Cho Y
    Nat Struct Biol; 1997 May; 4(5):390-5. PubMed ID: 9145110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a protein domain superfamily shared by the cyclins, TFIIB and RB/p107.
    Gibson TJ; Thompson JD; Blocker A; Kouzarides T
    Nucleic Acids Res; 1994 Mar; 22(6):946-52. PubMed ID: 8152925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helical fold prediction for the cyclin box.
    Bazan JF
    Proteins; 1996 Jan; 24(1):1-17. PubMed ID: 8628726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The crystal structure of cyclin A.
    Brown NR; Noble ME; Endicott JA; Garman EF; Wakatsuki S; Mitchell E; Rasmussen B; Hunt T; Johnson LN
    Structure; 1995 Nov; 3(11):1235-47. PubMed ID: 8591034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural principles in cell-cycle control: beyond the CDKs.
    Endicott JA; Noble ME
    Structure; 1998 May; 6(5):535-41. PubMed ID: 9634691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7.
    Lee JO; Russo AA; Pavletich NP
    Nature; 1998 Feb; 391(6670):859-65. PubMed ID: 9495340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.
    Kirch HC; Putzer B; Brockmann D; Esche H; Kloke O
    Eur J Biochem; 1997 Jun; 246(3):736-44. PubMed ID: 9219533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 'LXCXE' hydropathic superfamily of ligands for retinoblastoma protein: a proposal.
    Radulescu RT
    Med Hypotheses; 1995 Jan; 44(1):28-31. PubMed ID: 7776898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB.
    Hagemeier C; Bannister AJ; Cook A; Kouzarides T
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1580-4. PubMed ID: 8434021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein.
    Hall FL; Williams RT; Wu L; Wu F; Carbonaro-Hall DA; Harper JW; Warburton D
    Oncogene; 1993 May; 8(5):1377-84. PubMed ID: 8479754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle function of a Medicago sativa A2-type cyclin interacting with a PSTAIRE-type cyclin-dependent kinase and a retinoblastoma protein.
    Roudier F; Fedorova E; Györgyey J; Feher A; Brown S; Kondorosi A; Kondorosi E
    Plant J; 2000 Jul; 23(1):73-83. PubMed ID: 10929103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structure of the C-terminal core domain of human TFIIB: similarity to cyclin A and interaction with TATA-binding protein.
    Bagby S; Kim S; Maldonado E; Tong KI; Reinberg D; Ikura M
    Cell; 1995 Sep; 82(5):857-67. PubMed ID: 7671313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico characterization and molecular dynamics simulation of Pfcyc-1, a cyclin homolog of Plasmodium falciparum.
    Kaushik A; Subramaniam S; Gupta D
    J Biomol Struct Dyn; 2014; 32(10):1624-33. PubMed ID: 23998890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.
    Nakanishi M; Kaneko Y; Matsushime H; Ikeda K
    Biochem Biophys Res Commun; 1999 Sep; 263(1):35-40. PubMed ID: 10486249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin A and the retinoblastoma gene product complex with a common transcription factor.
    Bandara LR; Adamczewski JP; Hunt T; La Thangue NB
    Nature; 1991 Jul; 352(6332):249-51. PubMed ID: 1830372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F transcription factor is a target for the RB protein and the cyclin A protein.
    Nevins JR; Chellappan SP; Mudryj M; Hiebert S; Devoto S; Horowitz J; Hunter T; Pines J
    Cold Spring Harb Symp Quant Biol; 1991; 56():157-62. PubMed ID: 1840249
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of the cyclin E gene by transcription factor E2F1.
    Ohtani K; DeGregori J; Nevins JR
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12146-50. PubMed ID: 8618861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural characterization and specificity of expression of E2F-5: a new member of the E2F family of transcription factors.
    Itoh A; Levinson SF; Morita T; Kourembanas S; Brody JS; Mitsialis SA
    Cell Mol Biol Res; 1995; 41(3):147-54. PubMed ID: 8589754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of cyclins, cyclin-dependent kinases, RB and E2F1 in squamous-cell lung carcinoma.
    Volm M; Koomägi R; Rittgen W
    Int J Cancer; 1998 Jun; 79(3):294-9. PubMed ID: 9645354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.